Dialybrid Dialybrid announces its participation in the next edition of LSI Europe ’26 Emerging MedTech Summit in Barcelona, one of the key international gatherings for the MedTech and healthcare innovation ecosystem, bringing together executives, presenting startups, and active investors. Dialybrid Chief Technology Officer Stefania A. Riboldi will be attending the LSI (Life Science Intelligence) Europe ’26 Emerging MedTech Summit at the Grand Hyatt Barcelona, Spain, presenting the company on September 29 at 11:25 am CEST in Library B. In addition, she will be speaking during a panel discussion together with XGEN Venture MedTech Specialist & General Partner Luca Porro on September 30 at 10:30 am CEST in Track 5 – Loft Ballroom.
Dialybrid @ LSI Europe ’26 Emerging MedTech Summit, BARCELONA
